@Vulpes vulpes
Vous oubliez la dernière Dinesh et al., Journal of the Association of Physicians of India (Peer Reviewed).
https://www.japi.org/x284d434/hydroxychloroquine-for-sars-cov2-prophylaxis-in-healthcare-workers-ndash-a-multicentric-cohort-study-assessing-effectiveness-and-safety
Prophylaxis study with 2,727 Indian healthcare workers, showing lower risk of COVID-19 cases with treatment, and increasingly lower risk for longer durations of HCQ prophylaxis.
Risk of COVID-19 case, 60.1% lower, RR 0.40, p < 0.001,
treatment 247 of 617 (40.0%), control 611 of 1473 (41.5%), adjusted per
study, odds ratio converted to relative risk, >=6 weeks, logistic
regression.
Risk of COVID-19 case, 35.1% lower, RR 0.65, p < 0.001, treatment 88 of 185 (47.6%), control 611 of 1473 (41.5%), adjusted per study, odds ratio converted to relative risk, 4-5 weeks, logistic regression.
Ajouter une réaction
Pour réagir, identifiez-vous avec votre login / mot de passe